Wealth Effects LLC Scynexis Inc Transaction History

Wealth Effects LLC

$268 Million
Q3 2025

A detailed history of Wealth Effects LLC transactions in Scynexis Inc stock. As of the latest transaction made, Wealth Effects LLC holds 99,500 shares of SCYX stock, worth $58,705. This represents 0.03% of its overall portfolio holdings.

Number of Shares

99,500

Previous 99,500 -0.0%

Holding current value

$58,705

Previous $66,000 24.24%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$0.67 - $1.07 $6,700 - $10,700	10,000 Added 11.17%	99,500 $66,000
Q1 2025 Apr 23, 2025	SELL	$0.9 - $1.41 $4,050 - $6,345	-4,500 Reduced 4.79%	89,500 $85,000
Q4 2024 Jan 22, 2025	SELL	$1.0 - $1.53 $8,000 - $12,240	-8,000 Reduced 7.84%	94,000 $108,000
Q3 2024 Oct 21, 2024	SELL	$1.27 - $2.23 $12,065 - $21,185	-9,500 Reduced 8.52%	102,000 $151,000
Q2 2024 Aug 02, 2024	SELL	$1.4 - $2.77 $4,200 - $8,310	-3,000 Reduced 2.62%	111,500 $223,000

Q1 2024 Apr 22, 2024	SELL	$1.39 - $2.21 $4,170 - $6,630	-3,000 Reduced 2.55%	114,500 $168,000
Q4 2023 Jan 29, 2024	BUY	$1.56 - $2.24 $38,220 - $54,880	24,500 Added 26.34%	117,500 $262,000
Q3 2023 Oct 16, 2023	BUY	$1.93 - $3.64 $42,363 - $79,898	21,950 Added 30.89%	93,000 $212,000
Q2 2023 Jul 18, 2023	BUY	$2.38 - $3.67 $23,800 - $36,700	10,000 Added 16.38%	71,050 $209,000
Q1 2023 May 04, 2023	SELL	$1.15 - $3.0 $575 - $1,500	-500 Reduced 0.81%	61,050 $183,000
Q4 2022 Feb 02, 2023	SELL	$1.46 - $2.94 $37,960 - $76,440	-26,000 Reduced 29.7%	61,550 $96,000
Q3 2022 Nov 14, 2022	SELL	$1.83 - $2.93 $3,660 - $5,860	-2,000 Reduced 2.23%	87,550 $210,000
Q2 2022 Aug 03, 2022	SELL	$1.77 - $3.87 $4,425 - $9,675	-2,500 Reduced 2.72%	89,550 $167,000
Q1 2022 May 16, 2022	BUY	$3.56 - $6.66 $15,130 - $28,305	4,250 Added 4.84%	92,050 $360,000
Q4 2021 Feb 09, 2022	BUY	$4.94 - $7.69 $433,732 - $675,182	87,800 New	87,800 $536,000

Others Institutions Holding SCYX

# of Institutions

Shares Held

12.5M

Call Options Held

Put Options Held

View Full List

About SCYNEXIS INC

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $19.3M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

More about SCYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.

Account

Wealth Effects LLC Scynexis Inc Transaction History